Skip to content
Search

Latest Stories

FP34C submission deadline extended to May 6

Pharmaceutical Services Negotiating Committee (PSNC) notifies pharmacy contractors that the FP34C submission deadline has been extended to end of May 6.

This month the contractors get an extra day, because of a bank holiday on May 2, to submit their FP34C declaration through Manage Your Service (MYS) Portal for NHS pharmaceutical services delivered in April 2022.


PSNC added: “Contractors must also dispatch their prescription bundle to the relevant pricing division at the NHSBSA by May 6. This extended submission deadline applies to any month where one or more bank holiday occurs during the first five days of the month.”

“Please note the requirement to submit electronic Claim Notification (CN) messages or Electronic Reimbursement Endorsement Messages (EREMs) within the first five days remains unchanged. CN messages and EREMs for prescriptions dispensed in April 2022 must continue to be submitted by May 5, 2022.”

The earlier advance payment date will remain as four working days from the extended submission deadline of the sixth day of the month. Therefore, to secure access to earlier advance payments on May 12, 2022, contractors must submit their April 2022 FP34Cs through the MYS no later than May 6, 2022.

Contractors who submit their April FP34C figures late through MYS (after 6 May) will NOT receive any earlier advance payments and instead, receive their advance payments in accordance with the normal payment timetable i.e. on June 1, 2022.

Last month, over 10,700 pharmacy contractors who declared their March 2022 FP34C submission figures through the MYS by April 5 2022 received their earlier advance payments on Monday April 11 2022 (circa 20 days earlier than the normal advance payment timetable).

However, around 350 contractors submitted their FP34C figures late (after April 5). These contractors will receive their advance payments in accordance with the normal payment timetable i.e. on May 1 2022.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less